Retatrutide 10mg

Description

Retatrutide 10 mg is a research-grade synthetic peptide supplied in lyophilized form for use in controlled laboratory environments. It functions as a triple receptor agonist targeting glucose-dependent insulinotropic polypeptide, commonly known as GIP, glucagon-like peptide-1, commonly known as GLP-1, and glucagon receptors.

Its ability to activate three distinct G protein-coupled receptors within a single molecular structure makes Retatrutide a valuable tool for studying integrated metabolic signaling. In cellular assay systems, researchers may use this compound to examine how simultaneous activation of GIP, GLP-1, and glucagon receptor pathways influences intracellular signaling and pathway interactions.

The 10 mg presentation is well suited for preliminary investigations, assay development, receptor-binding evaluations, concentration-response studies, and pilot experiments using new cellular models.

Published research has explored Retatrutide in experimental systems involving pancreatic islet function, hepatic glucose signaling, energy regulation, and lipid metabolism in adipocyte models. Its triple-agonist activity provides a useful platform for comparing multi-receptor engagement with single and dual receptor activation.

Each vial from PEPTEX Labs is supplied as a research-grade lyophilized peptide and accompanied by analytical documentation. Testing may include HPLC purity analysis, mass spectrometry verification, net-content testing, and endotoxin analysis, depending on the individual production batch.

This product is supplied exclusively for qualified laboratory research. It is not intended for human or veterinary use.